Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice

Author:

Gan Lin1,Xie Xiaoxin1,Fu Yanhua1,Yang Xiaoyan2,Ma Shujing2,Kong Linghong2,Song Chunli1,Song Yebing1,Ren Tingting1,Long Hai1

Affiliation:

1. Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China

2. School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China

Funder

Science and Technology Foundation of Guizhou Province

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference30 articles.

1. AIDS group of journal of tropical diseases and parasitology branch of Chinese medical Association. Expert consensus on clinical application of integrase inhibitors;Hongzhou L.;Chin J Clin Infect Dis,2018

2. Professional group, Society of Infectious diseases, Chinese medical Association Chinese center for disease Control and Prevention. Chinese guidelines for diagnosis and treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome. 2021 ed;Acquired Immunodeficiency Syndrome and Hepatitis C;Chinese J AIDS & STD,2021

3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department Of Health And Human Services (DHHS). 2019 [cited Mar 22 2021]. Availabilie from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf.

4. European AIDS Clinical Society. Guidelines version 10.1 European AIDS Clinical Society (EACS). Oct 2020 [cited Mar 22 2021] . Available from: https://www.eacsociety.org/files/guidelines-10.1_finaljan2021_1.pdf.

5. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3